Breast Cancer Grand Round with A/Prof Helen Frazer

15 May 2024

Join A/Prof Helen Frazer as she shares how Artificial Intelligence (AI) has the potential to improve accuracy, client experience, and efficiency in breast cancer screening. Following promising results from retrospective real-world studies, hear about a randomised controlled trial planned for 2024.

Using Artificial Intelligence (AI), based on Deep Learning (DL) to help read mammograms, has the potential to transform breast cancer screening by improving accuracy, client experience, and efficiency. The evidence base for AI readers in breast cancer screening has been growing rapidly in recent years, with studies demonstrating the potential of AI to detect breast cancer on mammographic images with a similar accuracy to radiologists.

Following promising results from retrospective real-world studies, a randomised controlled trial will commence in 2024. It will provide implementation evidence to determine if using artificial intelligence (AI) with radiologists improves screening outcomes for Australian women.

The VCCC Alliance Breast Cancer Grand Round is targeted at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic. It is not appropriate for consumer participants.

Chair:

Prof Bruce Mann   MBBS  PhD
Professor of Surgery, the University of Melbourne; Director of Breast Tumour Stream, VCCC Alliance; Professor of Research, Breast Cancer Trials

With over 20-years’ experience, Professor Mann began his training in Melbourne followed by a PhD from the Ludwig Institute for Cancer Research and a fellowship the Memorial Sloan Kettering Cancer Centre, New York and the National Cancer Centre Hospital, Tokyo. 

A leader in collaborative enterprise, Professor Mann integrated the breast units of the Royal Melbourne Hospital with the Royal Women’s Hospital and was subsequently appointed Director of Breast Cancer Services bringing the breast unit at Peter MacCallum Cancer Centre together with the Royal Melbourne Hospital and Royal Women’s Hospital breast service. A major achievement in the breast tumour stream is the implementation of a Clinical Research and Information Management System; delivering comprehensive and searchable data, routinely collected from all patients treated for early breast cancer.